Acute myelomonocytic leukaemia (clinical)

disorder

SNOMED 110005000CUI C0023479

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Gemtuzumab ozogamicin

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Increased total leukocyte count

Very frequent (80-99%)HP:0001974

Low number of red blood cells or hemoglobin

Very frequent (80-99%)HP:0001903

Low platelet count

Very frequent (80-99%)HP:0001873

Bleeding tendency

Frequent (30-79%)HP:0001892

Difficulty breathing

Frequent (30-79%)HP:0002094

Paleness

Frequent (30-79%)HP:0000980

Weight loss

Frequent (30-79%)HP:0001824

Abnormality of the gingiva

Occasional (5-29%)HP:0000168

Eosinophilia

Occasional (5-29%)HP:0001880

Related Conditions

Acute myelomonocytic leukemia, FAB M4, in remission(child)

Acute myeloid leukemia(parent)

Myelomonocytic leukaemia(parent)

Quick Facts

SNOMED CT: 110005000
UMLS CUI: C0023479
Fully Specified Name: Acute myelomonocytic leukemia, FAB M4 (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 9
Known Treatments: 1

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.